Sterling Investment Advisors, Ltd. Dexcom Inc Transaction History

Sterling Investment Advisors, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$67.99 - $132.89 $72,001 - $140,730	1,059 Added 300.0%	1,412 $105,000
Q1 2022 May 03, 2022	BUY	$94.08 - $130.2 $28,224 - $39,060	300 Added 566.04%	353 $181,000
Q2 2021 Jul 29, 2021	BUY	$80.99 - $107.93 $242 - $323	3 Added 6.0%	53 $23,000
Q3 2020 Oct 26, 2020	BUY	$95.51 - $112.95 $1,241 - $1,468	13 Added 35.14%	50 $21,000
Q1 2020 Apr 30, 2020	BUY	$47.79 - $75.63 $573 - $907	12 Added 48.0%	37 $9,000
Q2 2019 Aug 06, 2019	BUY	$27.84 - $38.92 $139 - $194	5 Added 25.0%	25 $4,000
Q3 2018 Nov 09, 2018	BUY	$23.35 - $36.72 $303 - $477	13 Added 185.71%	20 $3,000
Q4 2017 Jan 29, 2018	BUY	$11.12 - $15.38 $77 - $107	7	7 $0

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sterling Investment Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Advisors, Ltd. with notifications on news.